Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
3. Boston Scientific’s Watchman misses 1 of 2 efficacy goals in PREVAIL trial
Medtech titan Boston Scientific finally unveils the full results from its PREVAIL study, which was the subject of controversy at last year’s ACC conference.
2. Allergan reveals FDA win, lobbies to keep Valeant out
Allergan lands FDA approval for its implantable eye drug and makes its case for keeping hostile buyer Valeant Pharmaceuticals from taking over the company’s R&D pipeline.
1. Podcast: Covidien’s Enxing Seng talks Medtronic merger, future of medicine at DeviceTalks
Covidien’s Stacy Enxing Seng speaks to MassDevice.com about the Medtronic merger during our DeviceTalks Minnesota event.